还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  


5 U) _0 k$ M" a/ t' l: P' C) y8 M. ?Sub-category:
Molecular Targets

% @4 h/ X# r& g- W1 `) `* S1 I: x
; |! o1 d- |8 l+ E5 MCategory:
Tumor Biology

+ M6 t1 O4 a/ H$ B9 P- z% m: ^
4 }9 D2 t$ t, j& A8 G  ^Meeting:
) L6 z2 y8 S/ m0 p7 M$ {3 r9 j+ E# a2011 ASCO Annual Meeting
" I" r' Y3 P) Y2 ~: B7 S8 j

$ y/ Z, q1 f; _1 H, @  CSession Type and Session Title:
Poster Discussion Session, Tumor Biology
# T! |2 H) r! Y% B

4 Q1 \2 J; M& d5 w9 RAbstract No:
% I, z/ _7 h0 t' J  b& m* B. o! M10517

  I( O  h- z: G) D# ]3 |- z7 l
Citation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)


4 V' S3 z- y# RAuthor(s):
$ j, A% J+ P9 a6 x3 x9 `2 zJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
% Y7 `4 N/ W  S/ W2 P; ?1 x# r
: @% G. a; I$ a) q3 V! `
1 E3 q6 w# `1 `) c
- a. M! R$ j  |" j" MAbstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
! S) e& i. m" l/ \0 t. J
Abstract Disclosures

Abstract:
% d0 `; N# Q3 C8 I! A
  a& j- h( E* J) o
% x3 ]+ U. l3 x2 s8 Y  eBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
8 ]% v  U# g* e8 C

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

* C) u& o$ e: v/ _# b  Y化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

' W3 z1 c; ]3 M; C' ^, N                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
; F1 k* f; D8 g6 T: ZALK一个指标医院要900多 ...

, m! s+ j+ ]: J1 N' q平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？

现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊